Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0490
0.00 (0.00%)
Oct 26, 2026, 12:43 PM AEDT
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 15.05 million as of October 29, 2026. It is the 41,111th most valuable company in the world and the 1,166th biggest in Australia. Its market cap has decreased by 44.61% in one year.
Market Cap
15.05M
Enterprise Value
19.33M
Revenue
1.43M
Global Rank
Country Rank
#1,166 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 15.05M, an increase of 8.25%. That is a compound annual growth rate of 0.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 15.05M | -44.61% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 20.27M |
| Proteomics International Laboratories | 19.84M |
| Algorae Pharmaceuticals | 18.25M |
| Imugene | 17.14M |
| ReNerve | 16.02M |
| Patrys | 15.72M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 14.36M |